Pharmaceutical

AI: Revolutionising Pharma R&D 

From one-size-fits-all to precision medicine: AI’s impact on pharma  Drug develo...

Arna Pharma and Slate Run complete JV for new US company

The companies are also launching their first collaboratively developed product, ...

Kyowa Kirin secures FDA approval for Crysvita dosing up...

Affecting adults and children, this rare, progressive, genetic disorder impacts ...

Indulekha Bringha Hair Growth Serum completes second cl...

Indulekha has announced the successful completion of its second large clinical ...

Lupin inaugurates Atharv Ability, an advanced multidisc...

Global pharma major Lupin announced the launch of Atharv Ability, its world-cla...

A uniform pricing regime ignores the heterogeneity with...

Dr Amit Kumar: How can policy frameworks better align commercial interests in t...

Zydus to acquire Assertio in $166m deal

The offer was approved by Assertio’s Board of Directors, following a revised mer...

Pfizer receives EC approval for Hympavzi to treat haemo...

The approval covers adults and adolescents in the European Union (EU) who weigh ...

Indoco Remedies clears Malta Medicines Authority audit

The facility has received EU GMP certification from the Malta Medicines Authori...

Lupin gets US FDA nod for Famotidine Injection, USP

This product would be manufactured at Lupin’s Nagpur facility in India The post...

Zydus to acquire Assertio in all-cash tender offer

Assertio is focused on specialty and oncology supportive-care therapies The pos...

AstraZeneca launches K+ Connect to advance hyperkalemia...

AstraZeneca Pharma India has launched K+ Connect, a pan-India multidisciplinary...

Lilly launches Lormalzi for treatment of early symptoma...

Eli Lilly and Company (India) announced the launch of Lormalzi (donanemab, 350 ...

UAE approves AstraZeneca’s Baxfendy for hypertension

With this authorisation, the UAE is said to become the first nation worldwide to...

Isomorphic Labs receives $2.1bn for AI drug development

The round was led by Thrive Capital, with participation from existing investors ...

Patent pause: Link extensions to pendency

India is now well-positioned to introduce a limited, risk-calibrated patent-ter...